Journal article
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation
Abstract
BACKGROUND: A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infarct-related artery, leading to an increased risk of complications and death.
METHODS: We enrolled 3491 patients, 18 to 75 years of age, who presented within 12 hours after the onset of an ST-elevation myocardial infarction and randomly assigned them to receive …
Authors
Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM
Journal
The New England Journal of Medicine, Vol. 352, No. 12, pp. 1179–1189
Publisher
Massachusetts Medical Society
Publication Date
March 24, 2005
DOI
10.1056/nejmoa050522
ISSN
0028-4793
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdultAgedAngioplasty, Balloon, CoronaryAspirinClopidogrelCoronary AngiographyCoronary Artery BypassDrug Therapy, CombinationElectrocardiographyFemaleFibrinolytic AgentsHemorrhageHeparinHumansMaleMiddle AgedMyocardial InfarctionPlatelet Aggregation InhibitorsSecondary PreventionThrombolytic TherapyTiclopidineVascular Patency